In a highly-anticipated decision, the United States Supreme Court announced today that compliance with the Food and Drug Administration’s food labeling guidelines is no defense against unfair competition claims brought by competitors under the Lanham Act. Quite the contrary – the Court found today, in the case of POM Wonderful LLC v. Coca-Cola Co., “powerful evidence that Congress did not intend FDA oversight to be the exclusive means of ensuring proper food and beverage labeling.”
